FORFARMERS NV (FFARM.AS) Stock Fundamental Analysis
AMS:FFARM - Euronext Amsterdam - NL0011832811 - Common Stock - Currency: EUR
Taking everything into account, FFARM scores 6 out of 10 in our fundamental rating. FFARM was compared to 55 industry peers in the Food Products industry. FFARM has an average financial health and profitability rating. FFARM is valued quite cheap, while showing a decent growth score. This is a good combination! This makes FFARM very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year FFARM was profitable.
FFARM had a positive operating cash flow in the past year.
FFARM had positive earnings in 4 of the past 5 years.
FFARM had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
FFARM has a Return On Assets (3.33%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 9.56%, FFARM is in the better half of the industry, outperforming 61.82% of the companies in the same industry.
FFARM's Return On Invested Capital of 7.90% is fine compared to the rest of the industry. FFARM outperforms 78.18% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FFARM is below the industry average of 6.56%.
The last Return On Invested Capital (7.90%) for FFARM is above the 3 year average (4.52%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.33% | ||
| ROE | 9.56% | ||
| ROIC | 7.9% |
ROA(3y)1.66%
ROA(5y)1.6%
ROE(3y)4.87%
ROE(5y)4.38%
ROIC(3y)4.52%
ROIC(5y)5.03%
1.3 Margins
FFARM has a Profit Margin of 1.14%. This is in the lower half of the industry: FFARM underperforms 63.64% of its industry peers.
In the last couple of years the Profit Margin of FFARM has grown nicely.
The Operating Margin of FFARM (2.02%) is worse than 65.45% of its industry peers.
FFARM's Operating Margin has been stable in the last couple of years.
The Gross Margin of FFARM (18.88%) is worse than 76.36% of its industry peers.
FFARM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.02% | ||
| PM (TTM) | 1.14% | ||
| GM | 18.88% |
OM growth 3Y22.91%
OM growth 5Y-1.24%
PM growth 3Y36.41%
PM growth 5Y9.73%
GM growth 3Y4.94%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so FFARM is still creating some value.
The number of shares outstanding for FFARM remains at a similar level compared to 1 year ago.
FFARM has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, FFARM has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.78 indicates that FFARM is not in any danger for bankruptcy at the moment.
FFARM has a Altman-Z score of 3.78. This is amongst the best in the industry. FFARM outperforms 89.09% of its industry peers.
FFARM has a debt to FCF ratio of 3.80. This is a good value and a sign of high solvency as FFARM would need 3.80 years to pay back of all of its debts.
FFARM's Debt to FCF ratio of 3.80 is fine compared to the rest of the industry. FFARM outperforms 80.00% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that FFARM is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.45, FFARM is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 3.8 | ||
| Altman-Z | 3.78 |
ROIC/WACC1.23
WACC6.44%
2.3 Liquidity
FFARM has a Current Ratio of 1.11. This is a normal value and indicates that FFARM is financially healthy and should not expect problems in meeting its short term obligations.
FFARM has a worse Current ratio (1.11) than 67.27% of its industry peers.
FFARM has a Quick Ratio of 1.11. This is a bad value and indicates that FFARM is not financially healthy enough and could expect problems in meeting its short term obligations.
FFARM has a Quick ratio (0.82) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
FFARM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 4895.65%, which is quite impressive.
Measured over the past years, FFARM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.71% on average per year.
Looking at the last year, FFARM shows a decrease in Revenue. The Revenue has decreased by -7.70% in the last year.
FFARM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.20% yearly.
EPS 1Y (TTM)4895.65%
EPS 3Y40.88%
EPS 5Y14.71%
EPS Q2Q%83.47%
Revenue 1Y (TTM)-7.7%
Revenue growth 3Y0.93%
Revenue growth 5Y2.2%
Sales Q2Q%1.62%
3.2 Future
FFARM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.03% yearly.
FFARM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.29% yearly.
EPS Next Y70.55%
EPS Next 2Y33.7%
EPS Next 3Y32.03%
EPS Next 5YN/A
Revenue Next Year6.99%
Revenue Next 2Y4.44%
Revenue Next 3Y5.29%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
FFARM is valuated reasonably with a Price/Earnings ratio of 11.47.
76.36% of the companies in the same industry are more expensive than FFARM, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of FFARM to the average of the S&P500 Index (28.04), we can say FFARM is valued rather cheaply.
With a Price/Forward Earnings ratio of 8.85, the valuation of FFARM can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FFARM indicates a rather cheap valuation: FFARM is cheaper than 81.82% of the companies listed in the same industry.
FFARM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 37.64.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.47 | ||
| Fwd PE | 8.85 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, FFARM is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, FFARM is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.05 | ||
| EV/EBITDA | 3.96 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FFARM's earnings are expected to grow with 32.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.16
PEG (5Y)0.78
EPS Next 2Y33.7%
EPS Next 3Y32.03%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 5.25%, FFARM is a good candidate for dividend investing.
FFARM's Dividend Yield is rather good when compared to the industry average which is at 3.28. FFARM pays more dividend than 89.09% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, FFARM pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.25% |
5.2 History
The dividend of FFARM decreases each year by -12.97%.
Dividend Growth(5Y)-12.97%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
FFARM pays out 41.40% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP41.4%
EPS Next 2Y33.7%
EPS Next 3Y32.03%
AMS:FFARM (7/25/2025, 7:00:00 PM)
3.785
-0.02 (-0.66%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners3.07%
Inst Owner ChangeN/A
Ins Owners5.48%
Ins Owner ChangeN/A
Market Cap337.92M
Analysts42.5
Price Target4.4 (16.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.25% |
Yearly Dividend0.15
Dividend Growth(5Y)-12.97%
DP41.4%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.78%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.47 | ||
| Fwd PE | 8.85 | ||
| P/S | 0.12 | ||
| P/FCF | 8.05 | ||
| P/OCF | 4.81 | ||
| P/B | 1.03 | ||
| P/tB | 1.62 | ||
| EV/EBITDA | 3.96 |
EPS(TTM)0.33
EY8.72%
EPS(NY)0.43
Fwd EY11.29%
FCF(TTM)0.47
FCFY12.43%
OCF(TTM)0.79
OCFY20.77%
SpS30.75
BVpS3.68
TBVpS2.34
PEG (NY)0.16
PEG (5Y)0.78
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.33% | ||
| ROE | 9.56% | ||
| ROCE | 10.29% | ||
| ROIC | 7.9% | ||
| ROICexc | 8.67% | ||
| ROICexgc | 11.28% | ||
| OM | 2.02% | ||
| PM (TTM) | 1.14% | ||
| GM | 18.88% | ||
| FCFM | 1.53% |
ROA(3y)1.66%
ROA(5y)1.6%
ROE(3y)4.87%
ROE(5y)4.38%
ROIC(3y)4.52%
ROIC(5y)5.03%
ROICexc(3y)5.02%
ROICexc(5y)6.01%
ROICexgc(3y)6.45%
ROICexgc(5y)7.81%
ROCE(3y)5.89%
ROCE(5y)6.6%
ROICexcg growth 3Y23.14%
ROICexcg growth 5Y0.01%
ROICexc growth 3Y22.42%
ROICexc growth 5Y1.04%
OM growth 3Y22.91%
OM growth 5Y-1.24%
PM growth 3Y36.41%
PM growth 5Y9.73%
GM growth 3Y4.94%
GM growth 5Y1.08%
F-Score6
Asset Turnover2.91
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 3.8 | ||
| Debt/EBITDA | 1.39 | ||
| Cap/Depr | 55.29% | ||
| Cap/Sales | 1.03% | ||
| Interest Coverage | 8.27 | ||
| Cash Conversion | 65.98% | ||
| Profit Quality | 133.76% | ||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 3.78 |
F-Score6
WACC6.44%
ROIC/WACC1.23
Cap/Depr(3y)70.12%
Cap/Depr(5y)76.46%
Cap/Sales(3y)1.08%
Cap/Sales(5y)1.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4895.65%
EPS 3Y40.88%
EPS 5Y14.71%
EPS Q2Q%83.47%
EPS Next Y70.55%
EPS Next 2Y33.7%
EPS Next 3Y32.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.7%
Revenue growth 3Y0.93%
Revenue growth 5Y2.2%
Sales Q2Q%1.62%
Revenue Next Year6.99%
Revenue Next 2Y4.44%
Revenue Next 3Y5.29%
Revenue Next 5YN/A
EBIT growth 1Y201.09%
EBIT growth 3Y24.06%
EBIT growth 5Y0.93%
EBIT Next Year188.1%
EBIT Next 3Y50.85%
EBIT Next 5YN/A
FCF growth 1Y-19.39%
FCF growth 3Y40.78%
FCF growth 5Y-6.65%
OCF growth 1Y-18.84%
OCF growth 3Y8.69%
OCF growth 5Y-6.1%